Crinetics Newsroom

TD Cowen Maintains Crinetics(CRNX.US) With Buy Rating

Moomoo News19minutes ago · Ratings

Crinetics Pharmaceuticals: Promising Outlook With Paltusotine Approval and Strategic Market Positioning

TipRanks21:55 ET

Earnings Flash (CRNX) Crinetics Pharmaceuticals Q1 Revenue $361,000 Vs. FactSet Est. $100,000

MT Newswires17:10 ET

Crinetics Pharmaceuticals $1.3B in Cash, Cash Equivalents, and Investment Securities as of March 31 >CRNX

Dow Jones16:53 ET

Express News | Crinetics Pharmaceuticals Inc: Cash Anticipated to Provide Runway Into 2029

Reuters16:38 ET

Crinetics Pharmaceuticals Q1 EPS $(1.04) Misses $(0.93) Estimate, Sales $361.00K Beat $90.91K Estimate

Benzinga16:33 ET

Crinetics Pharmaceuticals Reports Progress on Paltusotine NDA and Atumelnant Phase 3 Study Amid Strong Financial Position

Quiver Quantitative16:15 ET

Crinetics | 10-Q: Quarterly report

SEC16:15 ET · Announcements

Press Release: Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Dow Jones16:06 ET

Crinetics Pharmaceuticals 1Q Loss/Shr $1.04 >CRNX

Dow Jones16:06 ET

Express News | Crinetics Pharmaceuticals Q1 Operating Expenses USD 111.766 Million

Reuters16:05 ET

Earnings Preview: Crinetics to Report Financial Results Post-market on May 08

Moomoo NewsMay 2 21:00 ET

Piper Sandler Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $97

Moomoo NewsApr 29 03:33 ET · Ratings

LifeSci Capital Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $82

Moomoo NewsApr 29 03:33 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), GeneDx Holdings (WGS) and Teva Pharmaceutical (TEVA)

TipRanksApr 28 07:10 ET · Ratings

Crinetics Pharmaceuticals (CRNX) Gets a Buy From Piper Sandler

TipRanksApr 28 07:00 ET · Ratings

Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswireApr 11 08:00 ET

Express News | Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersApr 10 17:04 ET

Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireApr 10 17:04 ET

Crinetics Pharmaceuticals Says EMA Validates Marketing Authorization Application for Acromegaly Drug

MT NewswiresMar 27 16:46 ET